SCHEDULE: Artisan Partners Discloses 9.5% Stake in Twist Bioscience

Artisan Partners Asset Management Inc. and its affiliates have reported a 9.5% beneficial ownership stake in Twist Bioscience Corporation as of December 31, 2025.

Summary

• Artisan Partners Asset Management Inc. and its affiliated entities (Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership) collectively beneficially own 5,830,205 shares of Twist Bioscience Corporation common stock.
• This represents 9.5% of the total outstanding common stock of Twist Bioscience Corporation, based on 61,273,653 shares outstanding as of December 26, 2025.
• Artisan Partners holds shared voting power over 4,959,392 shares and shared dispositive power over all 5,830,205 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The shares are held on behalf of discretionary clients of Artisan Partners Limited Partnership, with clients entitled to dividends and sale proceeds.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a substantial stake by a major institutional investor like Artisan Partners typically signals confidence in Twist Bioscience's long-term value and strategic direction.

Positives

• A significant institutional investor, Artisan Partners, has taken a substantial 9.5% stake in Twist Bioscience, indicating confidence in the company's long-term prospects.
• The holding is for investment purposes in the ordinary course of business, suggesting a passive, long-term investment strategy rather than an activist one.

Risks

• The filing itself does not detail risks related to Twist Bioscience's operations.
• Potential for future share price volatility if Artisan Partners significantly alters its position, although the filing indicates a passive investment intent.

Future Outlook

This filing does not contain any forward-looking statements or guidance from Twist Bioscience Corporation. It solely reports the beneficial ownership stake of Artisan Partners.

Management Comments

• This filing does not contain notable quotes or paraphrased statements from Twist Bioscience Corporation's management. It includes certifications from Gregory K. Ramirez of Artisan Partners stating the securities were acquired and held in the ordinary course of business and not for influencing control.

Industry Context

StockSavvy.ai notes that a significant stake (9.5%) by a reputable asset manager like Artisan Partners in a biotechnology company such as Twist Bioscience can be viewed positively by the market. It signals institutional confidence in the company's technology, market position, or future growth prospects, potentially attracting further investor interest in the synthetic biology and genomics sector.

Comparison to Industry Standards

• StockSavvy.ai observes that a 9.5% stake is a substantial position for an institutional investor in a publicly traded company.
• While specific comparable companies or projects are not detailed in this filing, such a significant holding by a major asset manager like Artisan Partners, known for its fundamental research, often implies a strong conviction in the issuer's long-term value proposition relative to its peers in the biotechnology space.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake may instill greater confidence among existing shareholders and potentially attract new investors, positively impacting share price stability and liquidity.

Key Dates

Recommendation

The disclosure of a significant 9.5% stake by Artisan Partners is a positive signal, indicating institutional confidence in Twist Bioscience. However, as this is purely an ownership disclosure and not an operational update or financial performance report, it does not provide new fundamental data to warrant a 'buy' or 'sell' recommendation. A 'hold' recommendation is appropriate, acknowledging the positive sentiment from institutional backing while awaiting further operational or financial news from the company.

Keywords

Twist Bioscience, Artisan Partners, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, TBIO, Asset Management